With 10.70% CAGR, Lung Cancer Therapeutics Market Size to Surpass US$ 24.71 billion by 2030| Growth Plus Reports Pune, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The global lung cancer therapeutics market is expected to clock US$ 24.71 billion by 2030 at a 10.70% during the forecast period. As high prevalence of lung...

Asia-Pacific (APAC)Non-Small Cell Lung Cancer Therapeutics Markets growing at a CAGR of 8.7%, will be valued at $4.9 billion in 2022: ResearchMoz Albany, NY, June 01, 2016 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality globally. There were more than 1.8 million newly...